Cargando…
Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes
Despite many decades of investigation uncovering the autoimmune mechanisms underlying Type 1 Diabetes (T1D), translating these findings into effective therapeutics has proven extremely challenging. T1D is caused by autoreactive T cells that become inappropriately activated and kill the β cells in th...
Autores principales: | Volfson-Sedletsky, Victoria, Jones, Albert, Hernandez-Escalante, Jaileene, Dooms, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015774/ https://www.ncbi.nlm.nih.gov/pubmed/33815387 http://dx.doi.org/10.3389/fimmu.2021.635767 |
Ejemplares similares
-
Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes
por: Vazquez-Mateo, Cristina, et al.
Publicado: (2019) -
Regulation of T Follicular Helper Cells in Islet Autoimmunity
por: Serr, Isabelle, et al.
Publicado: (2018) -
The emerging role of regulatory cell-based therapy in autoimmune disease
por: Ghobadinezhad, Farbod, et al.
Publicado: (2022) -
Islet Autoimmunity in Adults With Impaired Glucose Tolerance and Recently Diagnosed, Treatment Naïve Type 2 Diabetes in the Restoring Insulin SEcretion (RISE) Study
por: Brooks-Worrell, Barbara M., et al.
Publicado: (2021) -
GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity
por: Zimmer, Niklas, et al.
Publicado: (2022)